SPORE in Pancreatic Cancer
In June 2016, researchers at Washington University School of Medicine in St. Louis received a Specialized Programs of Research Excellence (SPORE) grant, a major collaborative translational research award sponsored by the National Cancer Institute.
The SPORE grant will fund four projects, each resulting in a clinical trial. The projects include:
- Developing and testing personalized vaccines for PDAC patients based on their genetic factors
- Evaluating a strategy to overcome the immune suppression caused by tumors
- Screening combinations of drugs for inhibiting molecular pathways that foster tumor survival
- Developing a delivery platform for small-molecule drugs that sends drugs directly to tumors and avoids adverse side effects
The SPORE also funds a developmental research program, which offers grants for other pancreatic cancer research projects, and a career development program, which supports junior researchers on the path to pancreas cancer research.
More information on the Washington University SPORE in Pancreatic Cancer.